Hide Studies Not Open or Pending
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:July 24, 2023Active, not recruiting
Condition(s):Refractory Multiple MyelomaLast Updated:October 5, 2022Active, not recruiting
Condition(s):Relapsed Refractory Multiple MyelomaLast Updated:December 14, 2022Suspended
Condition(s):Relapsed and/or Refractory Multiple MyelomaLast Updated:November 4, 2021Recruiting
Condition(s):Relapsed/Refractory Multiple MyelomaLast Updated:August 14, 2023Active, not recruiting
Condition(s):Relapsed/Refractory Multiple MyelomaLast Updated:April 14, 2022Completed
Condition(s):Multiple Myeloma; Refractory Multiple MyelomaLast Updated:May 12, 2023Recruiting
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:December 8, 2022Completed
Condition(s):Relapsed and Refractory Multiple Myeloma (RRMM)Last Updated:July 28, 2023Active, not recruiting
Condition(s):Relapsed or Refractory Multiple MyelomaLast Updated:January 8, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.